ENTA

Enanta Pharmaceuticals Inc

May 19 • 04:00PM ET

13.76

+0.31 2.30 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: AVIR ABUS INO BNTC OCGN

| Held by: VTI IWM VXF IWN IBB VTWO SCHA DWAS VFMO IWC

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-2.59	Insider Own	5.09%	Shs Outstand	29.06M	Perf Week	-5.30%
Market Cap	400.12M	Forward P/E	-	EPS next Y	-1.75	Insider Trans	-0.86%	Shs Float	27.60M	Perf Month	-0.15%
Enterprise Value	422.97M	PEG	-	EPS next Q	-0.45	Inst Own	92.28%	Short Float	7.81%	Perf Quarter	-0.94%
Income	-61.98M	P/S	5.78	EPS this Y	40.73%	Inst Trans	15.60%	Short Ratio	12.63	Perf Half Y	14.10%
Sales	69.21M	P/B	3.43	EPS next Y	22.96%	ROA	-19.44%	Short Interest	2.16M	Perf YTD	-12.75%
Book/sh	4.01	P/C	2.44	EPS next 5Y	17.16%	ROE	-59.00%	52W High	17.15 -19.77%	Perf Year	130.87%
Cash/sh	5.63	P/FCF	-	EPS past 3/5Y	13.40% -16.17%	ROIC	-23.13%	52W Low	5.55 147.93%	Perf 3Y	-48.10%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-8.82% -11.81%	Gross Margin	92.87%	Volatility	5.11% 5.81%	Perf 5Y	-71.43%
Dividend TTM	-	EV/Sales	6.11	EPS Y/Y TTM	42.85%	Oper. Margin	-87.24%	ATR (14)	0.80	Perf 10Y	-40.30%
Dividend Ex-Date	-	Quick Ratio	3.84	Sales Y/Y TTM	7.37%	Profit Margin	-89.56%	RSI (14)	46.63	Recom	1.38
Dividend Gr. 3/5Y	- -	Current Ratio	3.84	EPS Q/Q	57.49%	SMA20	-2.65%	Beta	1.00	Target Price	20.62
Payout	-	Debt/Eq	1.60	Sales Q/Q	14.96%	SMA50	1.05%	Rel Volume	1.19	Prev Close	13.45
Employees	120	LT Debt/Eq	1.30	Earnings	May 11 AMC	SMA200	12.49%	Avg Volume	170.68K	Price	13.76
IPO	Mar 21, 2013	Option/Short	Yes / Yes	EPS/Sales Surpr.	7.65% 0.77%	Trades		Volume	203,871	Change	2.30%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)